These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study. Quigley EM; Vandeplassche L; Kerstens R; Ausma J Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970 [TBL] [Abstract][Full Text] [Related]
3. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031 [TBL] [Abstract][Full Text] [Related]
4. Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial. Coremans G; Kerstens R; De Pauw M; Stevens M Digestion; 2003; 67(1-2):82-9. PubMed ID: 12743445 [TBL] [Abstract][Full Text] [Related]
5. Prucalopride, a systemic enterokinetic, for the treatment of constipation. Emmanuel AV; Roy AJ; Nicholls TJ; Kamm MA Aliment Pharmacol Ther; 2002 Jul; 16(7):1347-56. PubMed ID: 12144586 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury. Krogh K; Jensen MB; Gandrup P; Laurberg S; Nilsson J; Kerstens R; De Pauw M Scand J Gastroenterol; 2002 Apr; 37(4):431-6. PubMed ID: 11989834 [TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled trial of prucalopride for severe chronic constipation. Camilleri M; Kerstens R; Rykx A; Vandeplassche L N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121 [TBL] [Abstract][Full Text] [Related]
8. Prucalopride: a review of its use in the management of chronic constipation. Keating GM Drugs; 2013 Nov; 73(17):1935-50. PubMed ID: 24194435 [TBL] [Abstract][Full Text] [Related]
9. Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation. Sloots CE; Poen AC; Kerstens R; Stevens M; De Pauw M; Van Oene JC; Meuwissen SG; Felt-Bersma RJ Aliment Pharmacol Ther; 2002 Apr; 16(4):759-67. PubMed ID: 11929394 [TBL] [Abstract][Full Text] [Related]
10. [Some practical questions on chronic stipsis treatment with prucalopride]. Bellacosa L; Cogliandro R; Cremon C; De Giorgio R; Barbara G; Stanghellini V Minerva Gastroenterol Dietol; 2014 Mar; 60(1):85-99. PubMed ID: 24632771 [TBL] [Abstract][Full Text] [Related]
11. Effect of prucalopride on symptoms of chronic constipation. Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation. Sloots CE; Rykx A; Cools M; Kerstens R; De Pauw M Dig Dis Sci; 2010 Oct; 55(10):2912-21. PubMed ID: 20428949 [TBL] [Abstract][Full Text] [Related]
13. Effect of prucalopride on intestinal gas tolerance in patients with functional bowel disorders and constipation. Malagelada C; Nieto A; Mendez S; Accarino A; Santos J; Malagelada JR; Azpiroz F J Gastroenterol Hepatol; 2017 Aug; 32(8):1457-1462. PubMed ID: 28090679 [TBL] [Abstract][Full Text] [Related]
14. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride. Tack J; Camilleri M; Dubois D; Vandeplassche L; Joseph A; Kerstens R Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251 [TBL] [Abstract][Full Text] [Related]
15. The association between prucalopride efficacy and constipation type. Jadav AM; McMullin CM; Smith J; Chapple K; Brown SR Tech Coloproctol; 2013 Oct; 17(5):555-9. PubMed ID: 23703575 [TBL] [Abstract][Full Text] [Related]
16. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies. Camilleri M; Van Outryve MJ; Beyens G; Kerstens R; Robinson P; Vandeplassche L Aliment Pharmacol Ther; 2010 Nov; 32(9):1113-23. PubMed ID: 21039673 [TBL] [Abstract][Full Text] [Related]
18. Oral prucalopride in children with functional constipation. Winter HS; Di Lorenzo C; Benninga MA; Gilger MA; Kearns GL; Hyman PE; Vandeplassche L; Ausma J; Hoppenbrouwers M J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):197-203. PubMed ID: 23535761 [TBL] [Abstract][Full Text] [Related]
19. Prucalopride is no more effective than placebo for children with functional constipation. Mugie SM; Korczowski B; Bodi P; Green A; Kerstens R; Ausma J; Ruth M; Levine A; Benninga MA Gastroenterology; 2014 Dec; 147(6):1285-95.e1. PubMed ID: 25239590 [TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation. Yiannakou Y; Piessevaux H; Bouchoucha M; Schiefke I; Filip R; Gabalec L; Dina I; Stephenson D; Kerstens R; Etherson K; Levine A Am J Gastroenterol; 2015 May; 110(5):741-8. PubMed ID: 25869393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]